quest biotechnology inc said its new subsidiary quest blood substitute inc signed agreement and plan merger with hunt research corp and its affiliate icas corp said quest blood expects complete merger within next several weeks terms were not disclosed related transaction quest blood said executed agreement with alza corp which will alza preferred shareholder quest blood and offer alza right acquire total equity position pct quest blood exchange for acquisition patent rights alza technology reuter 